Dr Chris Parker - PowerPoint PPT Presentation

1 / 26
About This Presentation
Title:

Dr Chris Parker

Description:

Dr Chris Parker. Senior Lecturer and Honorary Consultant in Clinical Oncology. Institute of Cancer Research and Royal Marsden Hospital London. Screening a ... – PowerPoint PPT presentation

Number of Views:41
Avg rating:3.0/5.0
Slides: 27
Provided by: meenal7
Category:
Tags: chris | oncology | parker

less

Transcript and Presenter's Notes

Title: Dr Chris Parker


1
(No Transcript)
2
Dr Chris Parker Senior Lecturer and Honorary
Consultant in Clinical Oncology Institute of
Cancer Research and Royal Marsden Hospital London
3
Screening a Distant Dream? Dr Chris
ParkerCancer Research UK Clinician
ScientistRoyal Marsden Hospital and Institute of
Cancer Research
South of England Prostate Cancer Collaborative
4
US public opinion on screening
Schwartz et al. JAMA 2004
5
What would an ideal prostate cancer test
do?How can we develop an ideal prostate cancer
test?
6
An ideal screening test
100
Risk of disease
0
Test result
7
The PSA test is far from ideal for screening
Risk of prostate cancer ()
PSA level (ng/ml)
Thompson et al. JNCI (2006)
8
Thompson et al. JNCI (2006)
9
What would an ideal prostate cancer test
do?How can we develop an ideal prostate cancer
test?
10
Not all prostate cancers are created equal
11
What would an ideal prostate cancer screening
test do?
  • avoid unnecessary treatment by identifying men
    with cancers that actually need to be treated
  • avoid unnecessary diagnosis by helping to
    identify who should or should not undergo
    prostate biopsy

12
Risk of prostate cancer Risk of high-grade
prostate cancer
Thompson et al. JNCI (2006)
13
Nomogram prediction for Gleason gt 7 prostate
cancer
Nam et al. Can J Urol (2006)
14
Nomogram prediction for Gleason gt 7 prostate
cancer
Nam et al. Can J Urol (2006)
15
Nomogram prediction for Gleason gt 7 prostate
cancer
Nam et al. Can J Urol (2006)
16
Nomogram prediction for Gleason gt 7 prostate
cancer
Nam et al. Can J Urol (2006)
17
Nomogram prediction for Gleason gt 7 prostate
cancer
Nam et al. Can J Urol (2006)
18
Nomogram prediction for Gleason gt 7 prostate
cancer
61 yr old white man, 40 ml gland, DRE normal, PSA
10 37 risk
Nam et al. Can J Urol (2006)
19
Nomogram prediction for Gleason gt 7 prostate
cancer
61 yr old white man, 75 ml gland, DRE normal, PSA
10 lt 10 risk
Nam et al. Can J Urol (2006)
20
Nomogram prediction for any prostate cancer
61 yr old white man, 75 ml gland, DRE normal, PSA
10 20 risk
Nam et al. Can J Urol (2006)
21
Nomogram prediction for Gleason gt 7 prostate
cancer
Ideal screening test
22
The PSA test is far from ideal for screening
100
Risk of prostate cancer
0
PSA level
23
The current situation
100
Risk of high-grade prostate cancer
0
Nomogram score
24
A distant dream
100
Risk of tiger
0
Nomogram score
25
What would an ideal prostate cancer screening
test do?
  • avoid unnecessary treatment by identifying men
    with cancers that actually need to be treated
  • avoid unnecessary diagnosis by helping to
    identify who should or should not undergo
    prostate biopsy

26
What would an ideal prostate cancer test
do?How can we develop an ideal prostate cancer
test?
Write a Comment
User Comments (0)
About PowerShow.com